Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis

Journal of Surgical Oncology

Volumn 111, Issue 2, 2015, Pages 158-164

  Naing, Khatija W ^a   Monjazeb, Arta M ^a   Li, Chin Shang ^b   Lee, L I Yuan ^c   Yang, Anthony ^a   Borys, Dariusz ^a   Canter, Robert J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Disease specific survival; Overall survival; Radiation therapy; Radical surgery; Synovial sarcoma

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SYNOVIAL SARCOMA; TUMOR LOCALIZATION; TUMOR VOLUME; ADJUVANT RADIOTHERAPY; AGE; ANCESTRY GROUP; CANCER GRADING; CANCER REGISTRY; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; UNITED STATES;

ADULT; AGE FACTORS; CONTINENTAL POPULATION GROUPS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; RADIOTHERAPY, ADJUVANT; SARCOMA, SYNOVIAL; SEER PROGRAM; SEX FACTORS; SOFT TISSUE NEOPLASMS; UNITED STATES;

EID: 84921568187     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23780     Document Type: Article

References (32)

1. Canter RJ, Beal S, Borys D, et al.: Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg 2010;210:191-198e192.
2. Sherman KL, Wayne JD, Chung J, et al.: Assessment of multimodality therapy use for extremity sarcoma in the United States. J Surg Oncol 2013;109:395-404.
3. Singer S, Demetri GD, Baldini EH, et al.: Management of soft-tissue sarcomas: An overview and update. Lancet Oncol 2000;1:75-85.
4. Katz SC, Brennan MF: Randomized clinical trials in soft tissue sarcoma. Surg Oncol Clin N Am 2010;19:1-11.
5. Eilber FC, Dry SM: Diagnosis and management of synovial sarcoma. J Surg Oncol 2008;97:314-320.
6. Canter RJ, Qin LX, Maki RG, et al.: A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res 2008;14:8191-8197.
7. Ferrari A, Gronchi A, Casanova M, et al.: Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004;101:627-634.
8. Guadagnolo BA, Zagars GK, Ballo MT, et al.: Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2007;69:1173-1180.
9. Koh KH, Cho EY, Kim DW, et al.: Multivariate analysis of prognostic factors in synovial sarcoma. Orthopedics 2009;32:824.
10. Trassard M, Le Doussal V, Hacene K, et al.: Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients. J Clin Oncol 2001;19:525-534.
11. Singer S, Baldini EH, Demetri GD, et al.: Synovial sarcoma: Prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 1996;14:1201-1208.
12. Wasif N, Smith CA, Tamurian RM, et al.: Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg 2013;148:632-639.
13. Eilber FC, Brennan MF, Eilber FR, et al.: Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 2007;246:105-113.
14. Rosen G, Forscher C, Lowenbraun S, et al.: Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 1994;73:2506-2511.
15. Kampe CE, Rosen G, Eilber F, et al.: Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease. Cancer 1993;72:2161-2169.
16. Al-Hussaini H, Hogg D, Blackstein ME, et al.: Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma. Sarcoma 2011;2011:231789.
17. Kraybill WG, Harris J, Spiro IJ, et al.: Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 2006;24:619-625.
18. Pisters PW: Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: Home run, base hit, or strike out? J Clin Oncol 2006;24:549-551.
19. Rhomberg W: The radiation response of sarcomas by histologic subtypes: A review with special emphasis given to results achieved with razoxane. Sarcoma 2006;2006:87367.
20. Raney RB: Synovial sarcoma in young people: Background, prognostic factors, and therapeutic questions. J Pediatr Hematol Oncol 2005;27:207-211.
21. Ferrari A, Casanova M, Massimino M, et al.: Synovial sarcoma: Report of a series of 25 consecutive children from a single institution. Med Pediatr Oncol 1999;32:32-37.
22. Park HS, Gross CP, Makarov DV, et al.: Immortal time bias:A frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2012;83:1365-1373.
23. Krieg AH, Hefti F, Speth BM, et al.: Synovial sarcomas usually metastasize after >5 years: A multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol 2011;22:458-467.
24. Lewis JJ, Antonescu CR, Leung DH, et al.: Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000;18:2087-2094.
25. Koshy M, Rich SE, Mohiuddin MM: Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: A SEER analysis. Int J Radiat Oncol Biol Phys 2010;77:203-209.
26. Yang JC, Chang AE, Baker AR, et al.: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197-203.
27. Beane JD, Yang JC, White D, et al.: Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20- year follow-up of a randomized prospective trial. Ann Surg Oncol 2014;21:2484-2489.
28. Schreiber D, Rineer J, Katsoulakis E, et al.: Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection. Am J Clin Oncol 2012;35:13-17.
29. Shi W, Indelicato DJ, Morris CG, et al.: Long-term treatment outcomes for patients with synovial sarcoma: A 40-year experience at the University of Florida. Am J Clin Oncol 2013;36:83-88.
30. Chen Y, Yang Y, Wang C, et al.: Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients. J Surg Oncol 2012;106:162-168.
31. Spillane AJ, A'Hern R, Judson IR, et al.: Synovial sarcoma: A clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000;18:3794-3803.
32. Thompson RC Jr, Garg A, Goswitz J, et al.: Synovial sarcoma. Large size predicts poor outcome. Clin Orthop Relat Res 2000;18-24.